Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 35% ± 13% | |
peripheral blood | 18 studies | 48% ± 13% | |
brain | 18 studies | 31% ± 17% | |
intestine | 11 studies | 30% ± 13% | |
eye | 11 studies | 29% ± 11% | |
kidney | 9 studies | 33% ± 11% | |
liver | 7 studies | 37% ± 21% | |
heart | 5 studies | 27% ± 4% | |
lymph node | 5 studies | 51% ± 8% | |
pancreas | 4 studies | 53% ± 14% | |
placenta | 4 studies | 33% ± 6% | |
bone marrow | 4 studies | 40% ± 13% | |
uterus | 4 studies | 43% ± 15% | |
breast | 4 studies | 35% ± 3% | |
prostate | 4 studies | 23% ± 8% | |
adipose | 4 studies | 30% ± 7% | |
esophagus | 3 studies | 41% ± 27% | |
skin | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4726.56 | 2642 / 2642 | 100% | 103.46 | 705 / 705 |
breast | 100% | 4479.08 | 459 / 459 | 100% | 96.02 | 1118 / 1118 |
esophagus | 100% | 4806.12 | 1445 / 1445 | 100% | 69.22 | 183 / 183 |
liver | 100% | 1968.89 | 226 / 226 | 100% | 49.33 | 406 / 406 |
ovary | 100% | 3992.76 | 180 / 180 | 100% | 121.20 | 430 / 430 |
pancreas | 100% | 2333.83 | 328 / 328 | 100% | 73.37 | 178 / 178 |
stomach | 100% | 3349.50 | 359 / 359 | 100% | 77.74 | 286 / 286 |
uterus | 100% | 4612.05 | 170 / 170 | 100% | 102.67 | 459 / 459 |
thymus | 100% | 4379.81 | 653 / 653 | 100% | 95.40 | 604 / 605 |
bladder | 100% | 4606.81 | 21 / 21 | 100% | 83.25 | 503 / 504 |
skin | 100% | 4529.99 | 1809 / 1809 | 100% | 72.02 | 471 / 472 |
lung | 100% | 4407.53 | 577 / 578 | 100% | 76.69 | 1153 / 1155 |
intestine | 100% | 4755.02 | 966 / 966 | 100% | 86.49 | 525 / 527 |
prostate | 100% | 3907.25 | 245 / 245 | 100% | 74.23 | 500 / 502 |
kidney | 100% | 4084.38 | 89 / 89 | 100% | 82.83 | 897 / 901 |
adrenal gland | 100% | 3530.32 | 258 / 258 | 98% | 70.62 | 226 / 230 |
adipose | 100% | 4577.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5197.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 133.86 | 29 / 29 |
muscle | 100% | 5932.66 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4533.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 100.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.58 | 1 / 1 |
peripheral blood | 99% | 4208.01 | 921 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 63.75 | 79 / 80 |
heart | 98% | 3476.10 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0036211 | Biological process | protein modification process |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | UBE2D2 |
Protein name | Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1) E2 ubiquitin-conjugating enzyme (EC 2.3.2.23) |
Synonyms | UBC5B UBC4 UBCH5B UBCH4 PUBC1 |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins . Catalyzes 'Lys-48'-linked polyubiquitination . Mediates the selective degradation of short-lived and abnormal proteins . Functions in the E6/E6-AP-induced ubiquitination of p53/TP53 . Mediates ubiquitination of PEX5 and SQSTM1 and autoubiquitination of STUB1 and TRAF6 . Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by RIGI in response to viral infection . Essential for viral activation of IRF3 . . |
Accessions | ENST00000398733.8 [P62837-1] ENST00000505548.5 [P62837-2] ENST00000398734.8 [P62837-1] P62837 ENST00000698322.1 [P62837-2] D6RFM0 ENST00000505007.5 ENST00000698321.1 [P62837-2] ENST00000511725.5 [P62837-2] |